Gera sveikata - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 10,270 | 12,276 | 11,917 | 15,367 | 20,745 | 23,139 | 25,624 | 24,539 |
| Profit before tax | -1,805 | 887 | 2,663 | 3,640 | 5,249 | 3,891 | 980 | -1,205 |
| Net profit | -1,805 | 887 | 2,594 | 3,456 | 4,984 | 3,694 | 931 | -1,205 |
| Equity | 532 | 1,419 | 4,013 | 7,469 | 13,596 | 17,290 | 18,222 | 17,017 |
| Liabilities | - | - | - | - | 4,095 | 30,877 | 27,549 | 19,452 |
| Non-current assets | 31,579 | 26,166 | 22,159 | 16,681 | 11,451 | 34,900 | 28,598 | 23,197 |
| Current assets | 2,793 | 2,154 | 5,029 | 10,176 | 21,396 | 13,267 | 17,173 | 13,272 |
| Total assets | 34,372 | 28,320 | 27,188 | 26,857 | 32,847 | 48,167 | 45,771 | 36,469 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,738 | 1,805 | 2,535 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +222.7% | +19.5% | -2.9% | +29.0% | +35.0% | +11.5% | +10.7% | -4.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -5.3% | 3.1% | 9.5% | 12.9% | 15.2% | 7.7% | 2.0% | -3.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -339.3% | 62.5% | 64.6% | 46.3% | 36.7% | 21.4% | 5.1% | -7.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -17.6% | 7.2% | 21.8% | 22.5% | 24.0% | 16.0% | 3.6% | -4.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -17.6% | 7.2% | 22.3% | 23.7% | 25.3% | 16.8% | 3.8% | -4.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.3 | 1.8 | 1.5 | 1.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gera sveikata - Social security debts
The company had no debts to Sodra
Gera sveikata - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gera sveikata, MB (company code 304450332) is a Lithuanian small partnership engaged in the retail sale of other medical and orthopaedic goods. In 2025, the company generated revenue of €24.5K, down 4.2% year on year from €25.6K in 2024. After two profitable years, it reported a net loss of €1.2K in 2025, compared with net profit of €931 in 2024 and €3.7K in 2023. The profit margin turned negative at -4.9%, reflecting weaker operating performance than in the previous periods. Over the three-year period, revenue remained broadly stable, rising from €23.1K in 2023 to €24.5K in 2025, while profitability declined materially. At year-end 2025, total assets stood at €36.5K, with equity of €17.0K and liabilities of €19.5K. The balance sheet shows an equity ratio of 46.7% and debt-to-equity of 1.14. Asset turnover was 0.67x, while ROE and ROA were negative at -7.1% and -3.3%, respectively.